Drugs / Tc-99m pertechnetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01437254 | Oct 2011 → Apr 2012 | thyroid tumor | AHS Cancer Control Alberta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tc-99m pertechnetate | “The cyclotron production model of Tc-99m pertechnetate (CPERT) has received significant validation” NCT01437254 ↗ |
| Known as | CPERT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01437254 ↗ |